Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. (Q44481322)

3 December 2017

title

Chronic renal insufficiency in children: the 2001 Annual Report of the NAPRTCS. (English)

1 reference

3 December 2017

Mouin G Seikaly

1

1 reference

3 December 2017

P L Ho

2

1 reference

3 December 2017

Lea Emmett

3

1 reference

3 December 2017

Richard N Fine

4

1 reference

3 December 2017

Amir Tejani

5

1 reference

3 December 2017

publication date

14 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

18

1 reference

3 December 2017

issue

8

1 reference

3 December 2017

page(s)

796-804

1 reference

Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure

3 December 2017

cites work

1 reference

12 December 2020

A randomized double-blind placebo-controlled trial of cyclosporine in steroid-resistant idiopathic focal segmental glomerulosclerosis in children

1 reference

12 December 2020

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

1 reference

12 December 2020

Anaemia in the patient with renal insufficiency: documenting the impact and reviewing treatment strategies

1 reference

12 December 2020

Optimizing medical management of patients with pre-end-stage renal disease

1 reference

12 December 2020

Malnutrition, cardiac disease, and mortality: an integrated point of view

1 reference

12 December 2020

Use of erythropoietin, active vitamin D3 metabolites, and alkali agents in predialysis patients

1 reference

12 December 2020

Mechanisms through which parathyroid hormone mediates its deleterious effects on organ function in uremia.

1 reference

12 December 2020

Pre-end-stage renal disease care in the United States: a state of disrepair

1 reference

12 December 2020

Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns.

1 reference

12 December 2020

Recombinant human erythropoietin therapy in children maintained by haemodialysis

1 reference

12 December 2020

Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis

1 reference

12 December 2020

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

12 December 2020

A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine

1 reference

12 December 2020

Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.

1 reference

12 December 2020

Delayed referral of black, Hispanic, and older patients with chronic renal failure

1 reference

12 December 2020

Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat.

1 reference

12 December 2020

Morbidity and mortality in dialysis patients

1 reference

12 December 2020

Recombinant human erythropoietin therapy in children on dialysis.

1 reference

12 December 2020

Low-dose subcutaneous recombinant erythropoietin in children with chronic renal failure. Australian and New Zealand Paediatric Nephrology Association

1 reference

12 December 2020

The role of phosphate in the secretion of parathyroid hormone in man

1 reference

12 December 2020

Early referral and its impact on emergent first dialyses, health care costs, and outcome

1 reference

12 December 2020

Disturbance of growth hormone--insulin-like growth factor axis in uraemia. Implications for recombinant human growth hormone treatment

1 reference

12 December 2020

Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis.

1 reference

12 December 2020

Inflammation and advanced glycation end products in uremia: simple coexistence, potentiation or causal relationship?

1 reference

12 December 2020

Screening for renal insufficiency: is it worth while? is it feasible?

1 reference

12 December 2020

Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency

1 reference

12 December 2020

Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind placebo-controlled study. Genentech Cooperative Study Group.

1 reference

12 December 2020

Prediction of creatinine clearance from serum creatinine

1 reference

12 December 2020

Differences in the modulating potential of advanced glycation end product (AGE) peptides versus AGE proteins

1 reference

12 December 2020

Effects of recombinant human erythropoietin on HLA sensitization and cell mediated immunity

1 reference

12 December 2020

Bone histology in incipient and advanced renal failure

1 reference

12 December 2020

Cardiovascular effects of recombinant human erythropoietin in predialysis patients

1 reference

12 December 2020

Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis

1 reference

12 December 2020

Chronic renal failure: factors influencing nephrology referral

1 reference

12 December 2020

Quality of life: subjective and objective improvements with recombinant human erythropoietin therapy

1 reference

12 December 2020

Clinical and laboratory features of patients with chronic renal disease at the start of dialysis

1 reference

12 December 2020

NKF-DOQI clinical practice guidelines for the treatment of anemia of chronic renal failure. National Kidney Foundation-Dialysis Outcomes Quality Initiative

1 reference

12 December 2020

10.1007/S00467-003-1158-5

Identifiers

DOI

1 reference

3 December 2017

1 reference